We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · August 22, 2020

Residual Risks of Ischemic Stroke and Systemic Embolism Among AF Patients With Anticoagulation

Heart (British Cardiac Society)

 

Additional Info

Heart (British Cardiac Society)
Residual Risks of Ischaemic Stroke and Systemic Embolism Among Atrial Fibrillation Patients With Anticoagulation: Large-Scale Real-World Data (F-CREATE Project)
Heart 2020 Aug 14;[EPub Ahead of Print], T Maeda, T Nishi, S Funakoshi, et al

Further Reading